Frontlight ResearchEarly access
Trial site
The Retina Group of Washington
- 6running trials
- 1closed trial
The trials here
What the 7 trials at this site are about, from their registry records.
- Conditions
- Macular degeneration4 trials
- Diabetic eye disease2 trials
- Retinitis pigmentosa1 trial
- Phase
- Phase 35 trials
- Phase 21 trial
- Status
- Active, not recruiting4 trials
- Recruiting2 trials
- Completed1 trial
- Lead sponsor
- EyePoint Pharmaceuticals, Inc.2 trials
- 4D Molecular Therapeutics1 trial
- Alkeus Pharmaceuticals, Inc.1 trial
- Apellis Pharmaceuticals, Inc.1 trial
- Astellas Pharma Global Development, Inc.1 trial
- and 1 more
Running trials
Recruiting
A Phase 3 Trial for Intravitreal Injection of 4D-150 in Adults With Diabetic Macular Edema (DME).
Recruiting
Active, not recruiting
Active, not recruiting
Safety of a Single, Intravitreal Injection of 6.0M jCell (Famzeretcel) in Retinitis Pigmentosa (RP)
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Diabetic eye disease1 recruiting
- Macular degeneration1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026